Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
29 people get IGI articles and Market Currents by email alert.
Get email alerts on IGI »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
There are no Transcripts on IGI.
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Apr 11, 2013)
-
Business Wire (Feb 4, 2013)
-
Business Wire (Nov 8, 2012)
-
Business Wire (Nov 2, 2012)
-
at Fox Business (Aug 23, 2012)
-
at Fox Business (Aug 23, 2012)
-
at Fox Business (Aug 23, 2012)
-
at Fox Business (Aug 23, 2012)
-
at Fox Business (Aug 23, 2012)
-
Business Wire (Aug 2, 2012)
-
Business Wire (May 1, 2012)
-
Business Wire (Apr 19, 2012)
IGI vs. ETF Alternatives
Company Description
Currently, there's no company description for IGI.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, February 15, 11:58 AM IGI Laboratories (IG +2.2%) trades up after signing a three-year agreement with Juventio LLC to manufacture and supply finished dose forms of certain cosmetic and OTC products and formulations owned and developed by IGI. The products utilize encapsulation technology trademarked as Novasome for which the company currently holds an exclusive license. Comment! [Healthcare, On the Move]
- Friday, November 16, 2012, 3:44 PM Not all closed-end funds trade at premiums to NAV, and for the ones at discounts, recent declines in their stock price - but not their value - has made them even more attractive. The favorites of UBS' Sangeeta Marfatia: IGI, [[iGR]], HPS, and HTD. Comment!